These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 234637)

  • 21. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.
    Mohri H; Noguchi T; Kodama F; Itoh A; Ohkubo T
    Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand's disease.
    Hagedorn B
    JAMA; 1971 May; 216(6):991-5. PubMed ID: 4929581
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of aspirin on the exercise-induced changes in platelet function and blood coagulation.
    Davies T; Lederer DA; Davies JA; McNicol GP
    Thromb Res; 1974 Jul; 5(1):69-81. PubMed ID: 4610889
    [No Abstract]   [Full Text] [Related]  

  • 24. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion.
    Chediak JR; Telfer MC; Green D
    Am J Med; 1977 Mar; 62(3):369-76. PubMed ID: 300224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The coagulant activity of platelets.
    Biggs R; Denson KW; Riesenberg D; McIntyre C
    Br J Haematol; 1968 Sep; 15(3):283-96. PubMed ID: 5303048
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitivity of platelets to aspirin in von Willebrand's disease.
    Leslie J; Mason DY
    J Clin Pathol; 1970 Sep; 23(6):526-8. PubMed ID: 5312233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: 8-related antigen and von Willebrand factor.
    Firkin B; Koutts J
    Lancet; 1974 Apr; 1(7861):803-4. PubMed ID: 4132731
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of dihydroergotamine on platelets, coagulation and fibrinolysis, studied in healthy humans and in dogs.
    Lindblad B; Bergqvist D; Hedner U
    Thromb Res; 1983 Oct; 32(1):35-44. PubMed ID: 6419372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
    Morin RJ; Chen AF; Narayanan AS; Raye C; Moss RA; Srikantaiah MV; Barajas L
    Thromb Res; 1980 Mar; 17(5):719-28. PubMed ID: 6770486
    [No Abstract]   [Full Text] [Related]  

  • 32. Von Willebrand factor and platelet adhesiveness.
    Meyer D; Larrieu MJ
    J Clin Pathol; 1970 Apr; 23(3):228-31. PubMed ID: 5310275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets and von Willebrand disease.
    Ruggeri ZM; Zimmerman TS
    Semin Hematol; 1985 Jul; 22(3):203-18. PubMed ID: 3929388
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombopathy. Identification and distribution.
    Sanfelippo MJ; Hussey CV
    Am J Clin Pathol; 1974 May; 61(5):628-38. PubMed ID: 4545272
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical investigation of intermediate- and high-purity antihaemophilic factor (factor VIII) concentrates.
    Johnson AJ; Karpatkin MH; Newman J
    Br J Haematol; 1971 Jul; 21(1):21-41. PubMed ID: 5314809
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biological diagnosis of von Willebrand's disease (author's transl)].
    Castillo R; Maragall S; Liendo F; Ordinas A
    Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168
    [No Abstract]   [Full Text] [Related]  

  • 38. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII.
    Walsh PN
    Br J Haematol; 1972 Apr; 22(4):393-405. PubMed ID: 5028124
    [No Abstract]   [Full Text] [Related]  

  • 40. Kinetic distinction of two mechanisms for platelet retention.
    Cronberg S; Holmberg L
    Scand J Haematol; 1973; 11(5):372-8. PubMed ID: 4544303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.